Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-16

Clinical Trial Update: Therapeutic Effects of Immuno-targeted Therapy Combined With or Without RT for HCC

View source ↗

Summary

A clinical trial investigating immuno-targeted therapy with or without radiotherapy for hepatocellular carcinoma; recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Hepatocellular Carcinoma (HCC) | Status: NOT_YET_RECRUITING